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Free radicalsVarious nutritional, behavioral, and pharmacological interventions have been previously shown to extend
life span in diverse model organisms, including Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila
melanogaster, mice, and rats, as well as possibly monkeys and humans. This review aims to summarize
published evidence that several longevity-promoting interventions may converge by causing an activation of
mitochondrial oxygen consumption to promote increased formation of reactive oxygen species (ROS). These
serve as molecular signals to exert downstream effects to ultimately induce endogenous defense mechanisms
culminating in increased stress resistance and longevity, an adaptive response more speciﬁcally named
mitochondrial hormesis or mitohormesis. Consistently, we here summarize ﬁndings that antioxidant
supplements that prevent these ROS signals interfere with the health-promoting and life-span-extending
capabilities of calorie restriction and physical exercise. Taken together and consistent with ample published
evidence, the ﬁndings summarized here question Harman's Free Radical Theory of Aging and rather suggest
that ROS act as essential signaling molecules to promote metabolic health and longevity.utrition, Institute of Nutrition,
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Calorie restriction (CR), i.e., a reduction in ad libitum calorie up-
take by 10 to 50%, represents the most convincing intervention to
retard aging and attenuate age-related disease in multiple species.
Since 1935, when McCay initially described the inﬂuence of CR on life
expectancy, it has been frequently demonstrated that CR is able to
increase the median and maximal life span in a variety of organisms,
suggesting a conserved underlying mechanism [1,2].Although CR clearly reduces risk factors associated with aging in
humans, including type 2 diabetes and cardiovascular diseases, it is still
a matter of debate whether CR is capable of increasing life expectancy
of humans [3–5]. A recent study in nonhuman primates found no
signiﬁcant effect of CR on overall mortality. However, arbitrarily
deﬁned “age-related mortality” (which moreover explained only 54%
of deaths) was decreased in those monkeys. Most interestingly and
contrasting with ad libitum-fed animals, monkeys on CR did not show
any impairment in glucose homeostasis, strikingly reducing the
prevalence of metabolic disorders such as type 2 diabetes [6]. Thus, it
seems possible that CR is also sufﬁcient to improve the life span of
humans, which is also supported by additional ﬁndings [3–5,7,8].
The concept of CR was initially based on the assumption that
lowering caloric intake would result in a subsequent reduction of the
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century that the maximum life span of an organism is inversely
proportional to the nutritive energy metabolized [9]. Consequently,
Pearl's Rate-of-Living Hypothesis, formulated soon after, suggests that
increased metabolic rate results in decreased life span in eukaryotes
[10].
A feasible molecular cause for this hypothesis was proposed in
1956 by Harman, who connected metabolic activity, especially that
of respiratory enzymes, with the formation of potentially harmful
reactive oxygen species (ROS) [11]. Accordingly, increased metabolic
rate would promote ROS formation, which subsequently causes
damages within the cell and beyond. The accumulation of these
damages results in age-related decline of cellular functions and
ultimately to death of the organism [11]. Up to now, this so-called Free
Radical Theory of Aging (FRTA) has become a popular and frequently
cited theory in aging research [12].
However, more recent ﬁndings regarding the question whether
CR actually decreases metabolic rate are, at least in part, inconsistent
with FRTA. Hence, it has been reported that CR increases metabolic
rate (quantiﬁed by both oxygen consumption and heat production) in
the nematode and well-established model organism for aging
research, Caenorhabditis elegans [13]. Furthermore, a positive corre-
lation between low metabolic rate and enhanced life span could also
not be observed in the fruitﬂy Drosophila melanogaster [14].
Despite the fact that CR has been extensively investigated in a
broad range of species, the underlyingmechanisms are still elusive. As
mentioned above, it is commonly accepted that CR is able to retard the
onset of a variety of diseases related to aging, including cardiovascular
diseases, type 2 diabetes, and cancer. Therefore, CR-mediated pre-
vention of chronic and ultimately life-threatening disorders that
reduce longevity could be the reason for the life-span-extending
effects of CR. Additionally, it has been shown that CR itself stimulates
molecular processes that diminish age-associated disease as well as
improving life expectancy. Accordingly, it was frequently reported
that CR induces defense mechanisms, especially those that are
involved in ROS detoxiﬁcation such as radical-scavenging enzymes
[15–22] and possibly beyond, including phase II response enzymes.
This association of CR on the one hand and increased antioxidant
defense on the other has been commonly misinterpreted as being
caused by a primarily decreased ROS production in states of CR.
Conversely, and as explained in more detail below, more recent
investigations suggest that adaptive response mechanisms seem to be
the cause of the aforementioned beneﬁcial alterations unquestionably
initiated by CR [23–27].
Reduction of speciﬁc macronutrients
Macronutrients are represented by carbohydrates, triglycerides,
and proteins, which, after experiencing enzymatic breakdown, are
ultimately metabolized as monosaccharides (such as glucose), fatty
acids, and amino acids, respectively. They provide the bulk of energy
required by the organism. In this regard it should be noted, however,
that only glucose can be metabolized in the absence of oxygen. In
contrast, ATP generation using fatty acids and some amino acids
requires mitochondrial oxidative phosphorylation (OxPhos) and
therefore oxygen. Inversely, only metabolism of glucose can generate
ATP independent of mitochondrial organelles and hence without
promoting ROS production.
So far, only a few studies have investigated the question whether
restricting a single macronutrient can cause a response comparable to
that seen in states of general CR. Whereas restriction of triglyceride
uptake in invertebrates has not been examined yet, restriction of
lipids in mice without CR does not inﬂuence life span [28].
The inﬂuence of dietary protein levels on life span has been
investigated primarily in D. melanogaster and rodents. Accordingly, it
was shown that reduction of nutritive protein content results inextension of life expectancy in mice [29–31]. Similarly, casein
restriction prolongs life span in D. melanogaster [32]. On the other
hand, supplementation of essential amino acids, especially methio-
nine, abolishes the life-span-extending effect of CR in ﬂies [33].
Interestingly, methionine restriction in rodents has been shown to
exert antiaging properties and improves tissue-speciﬁc mitochondrial
biogenesis as well as aerobic capacity [34–36], whereas high protein
intake results in increased lipid peroxidation and reduced superoxide
dismutase activity [37]. Consistently, impaired peptide transport
extents life span in C. elegans [38].
In apparent contrast to the above-mentioned fact that ATP
generation from glucose is capable of avoiding ROS production,
glucose restriction has been found to be beneﬁcial in various lower
organisms as well as in rodents. In D. melanogaster, for instance,
restriction of sugar reduces mortality and extends life span [39]. The
same applies for the model organism Saccharomyces cerevisiae, in
which depletion of glucose results in life-span extension dependent
on induction of respiration as well as on sirtuins [40,41]. However,
whether sirtuins are involved is still a matter of debate [42–45].
Accordingly, sirtuin-independent pathways have been discussed
[22,46].
Although it is generally difﬁcult to restrict dietary glucose in
eukaryotic organisms such as C. elegans or rodents, the use of 2-
deoxyglucose (DOG) is frequently reported to achieve depletion of
glucose metabolism [47]. DOG is a synthetic glucose analogue that
inhibits glycolysis in a competitive manner due to its inability to be
further metabolized after conversion into deoxyglucose 6-phosphate
[48]. Application of DOG was shown to mimic a ketogenic diet (very
low carbohydrate diet) as well as metabolic hallmarks of CR in rodents
[49–51]. It is therefore commonly accepted that DOG represent a
powerful CR-mimetic compound [52–55].
DOG exposure results in decreased glucose availability and life-
span extension in C. elegans [23], whereas it does not extend life span
in rats [56]. Notably, and similar to the above-mentioned ﬁndings in S.
cerevisiae, glucose restriction in C. elegans not only promotes life span
but also increases oxygen consumption [23]. However, and in contrast
to yeast, in nematodes sirtuins seem not to be involved [23]. It was
suggested instead that the underlying mechanism in regard to life-
span prolongation is dependent on AMP-activated kinase (AMPK)
[23]. AMPK is assumed to be a central key regulator of energy
metabolism within the cell [57]. Functionally similar AMPK ortholo-
gues have been found in lower organisms such as worms and ﬂies,
suggesting a highly conserved mechanism [58–60]. Metabolic stress,
e.g., cellular lack of energy, activates AMPK, which in turn up-
regulates energy-producing processes such as mitochondrial biogen-
esis leading to neutralization of the energy deﬁcit, possibly with
additional health-promoting implications [57]. Consistently, applying
metformin, a long-standing antidiabetic drug, to C. elegans activates
AMPK and subsequently promotes adaptive processes involved in CR
and oxidative stress response, culminating in extended life span [61].
As an alternative approach to inﬂuencing intracellular glucose
concentrations in mammals, mice with impaired GLUT-4 transporters
in muscle and adipose tissue were established. These mice show
typical metabolic switches such as fasting hyperglycemia, glucose
intolerance, increased fatty acid turnover, and utilization. However,
life span (examined up to 18 months of age) was not affected [62].
Increased cellular glucose availability due to overexpression of GLUT-
4, on the other hand, was also shown to lack any effect regarding
extension of life span [63]. In addition, increased glucose abundance
in C. elegans, examined in three independent studies, reduces life span
signiﬁcantly [23,64,65].
In humans, varying the relative amounts of macronutrients within
diets has been postulated to be health beneﬁcial in regard to obesity
and cardiovascular disease prevention. Although low-carbohydrate/
high-protein diets are as efﬁcient as low-fat/high-carbohydrate diets
in regard to weight loss, serum parameters known to determine
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reduction in dietary carbohydrate consumption [66–68]. Very low
carbohydrate diet has been also demonstrated to reduce several
inﬂammation markers in overweight men and women with athero-
genic dyslipidemia [69]. However, more research, especially long-
term studies, is needed to evaluate the putative effect of low-carbo-
hydrate diets on human health.
Impaired insulin/IGF-1 signaling
In mammals, insulin and IGF-1 represent peptide hormones
produced in pancreatic β-cells and liver, respectively. Insulin is a
regulator of the peripheral glucose metabolism, most notably glucose
uptake. In addition, insulin is also involved in other metabolic
processes such as fat metabolism. IGF-1 is produced as a consequence
of growth hormone (GH) (also called somatotropin) release from the
pituitary gland, which stimulates subsequently IGF-1 production in
the liver. IGF-1 is therefore a mediator for some of the GH functions,
thus involved in growth and anabolism. Insulin, IGF-1, and GH
mediate their effects by binding at speciﬁc and distinct receptors in
mammals.
Mice with reduced GH and/or IGF-1 signaling exhibit dwarﬁsm
with a phenotype that is comparable to those of mice exposed to CR
[70]. As shown for CR, those mice are also long-lived [71]. Conversely,
increasing GH availability leads to improved body size and diminishes
life expectancy [72,73]. Furthermore, heterozygote impairment of the
IGF-1 receptor signaling in the entire animal, as well as impairment of
the IGF-1 receptor in neurons, results in life-span extension inmice by
preventing neurodegenerative processes [74,75]. Conversely, long-
term IGF-1 exposure leads to mitochondrial dysfunction and reduced
cell viability in human cell culture [76].
Down-regulation of insulin receptor activity in humans is assumed
to be a cause for insulin resistance. This state is deﬁned as an inappro-
priate reduction in the intracellular response to extracellular insulin
[77]. Consequently, a reduction in GLUT-4-mediated glucose uptake,
which represents a key insulin response, occurs. Therefore, intracel-
lular glucose availability is reduced in subjects suffering from insulin
resistance [78].
However, despite the fact that global disturbance of the insulin
receptor in mice results in a prenatally lethal phenotype, muscle-
speciﬁc knockout mice experience neither hyperglycemia nor
diabetes. Instead, a remarkable rise in fatty acid turnover has been
observed [79]. Although life-span data on these mice are unavailable,
disruption of the insulin receptor in adipose tissue only causes
prolongation of life span [80]. Moreover, disruption of the insulin
receptor substrate 1 (IRS-1), which is localized downstream of both
the insulin and the IGF-1 receptors, is associated with murine lon-
gevity as well as knockouts of neuronal IRS-2 and heterozygous global
IRS-2 [81,82].
Moreover, and as initially published more than 20 years ago,
impaired insulin/IGF-1 signaling strikingly prevents aging in inverte-
brates. Whereas in mammals insulin and IGF-1 bind to speciﬁc and
distinct receptors, in C. elegans and D. melanogaster insulin and IGF-1
signaling is limited to one receptor. Hence, mutations in the corre-
sponding receptor orthologues as well as in downstream components
were shown to be life-span extending in worms and ﬂies in a manner
even more pronounced than in mammals [83–87]. C. elegans daf-2
mutants, which show impaired activity of the orthologue of the
mammalian insulin/IGF-1 receptor, live twice as long as wild-type
nematodes [84]. Although it is not known whether glucose uptake or
intracellular glucose availability is affected in this regard, a very recent
work on daf-2 mutants indicates that the age-associated decline in
mitochondrial activity, e.g., mitochondrial protein content and energy
supply, is delayed in comparison to wild-type animals [88].
In summary, it seems that reduction of the insulin receptor as well
as insulin receptor substrate below a certain threshold contributes tolongevity in a variety of organisms, including worms, ﬂies, and mice.
This may be also relevant to humans because mutations of insulin/
IGF-1 signaling have been linked to regulation of life expectancy in
various cohorts [89,90].
Whether reduced insulin/IGF-1/GH signaling lengthens life span in
the same manner as CR is an ongoing matter of debate. Although
several studies have demonstrated independent mechanisms, others
have proposed that similar pathways and processes are initiated
by both interventions [59,91–101]. Based on the assumption that
mutations associated with impaired insulin/IGF-1 signaling cause
reduced intracellular glucose availability, it seems likely that
subsequent effects are comparable to those seen in glucose-restricted
model organisms, at least in regard to metabolic shifts and also
possibly life-span-extending mechanisms. Although to date direct
evidence is missing, some studies provide support for this hypothesis
[102–106].
Induction of mitochondrial metabolism by calorie/glucose
restriction
In general, mitochondria are cellular organelles that provide the
bulk of energy within the cell. ATP generation due to mitochondrial
OxPhos is considerably more efﬁcient in comparison to nonoxidative
metabolism of glucose and some amino acids. Whereas glycolytic
breakdown of 1 mol of glucose generates 4 mol of ATP, its oxidative
metabolism produces 30 mol of ATP. Mitochondria also produce ROS
as a by-product of OxPhos. Thus, being the main producer of cellular
energy as well as a source of potentially harmful ROS, mitochondria
appear to exert a central role in physiological and pathophysiological
processes.
Accordingly, mitochondrial dysfunction is associated with the
onset of age-related diseases such as diabetes, cancer, and neurode-
generation [107–110]. Furthermore, impairment of mitochondrial
activity is assumed to be a main cause of the aging process [111,112].
Whether this decrease in mitochondrial capacity is linked to altered
production of mitochondrial ROS seems questionable.
Although a few studies suggested that overall net calorie uptake
during the lifetime is unaltered in CR [39,113], it is commonly
accepted and agreed upon that by deﬁnition calorie/glucose restric-
tion causes a reduction in available nutritive energy. This short-term
energy deﬁcit has been proposed to induce mitochondrial activity to
counteract the energy depletion. Accordingly, calorie/glucose restric-
tion causes an increase in mitochondrial respiration in yeast and
worms [23–25,40]. Enhanced mitochondrial activity is, as shown in
these studies, associated with life-span extension [23–25,40]. Fur-
thermore, CR promotes mitochondria biogenesis and OxPhos in
rodents as well as enhancement of respiratory capacity in mammalian
cells [114,115]. These results are in line with the observation that
energy expenditure as a function of body mass is unexpectedly
increased in calorie-restricted rats [116]. Moreover, as mentioned
before, reduced insulin/IGF-1/GH signaling stimulates mitochondria
metabolism in rodents [102,104–106]. In addition, an abundant
supply of branched-chain amino acids increases mitochondrial
biogenesis and promotes longevity in yeast and mice [117,118].
Finally, further interventions that induce mitochondrial activity, such
as pharmacological treatments and physical exercise, are capable of
improving life span [119–123].
In contrast, and as mentioned before, reduced mitochondrial
activity has been shown to decrease life span in various organisms
such as S. cerevisiae, C. elegans, and rodents [124–126].
In regard to proposed mechanisms involved in the activation of
mitochondrial metabolism some key cellular regulators have been
frequently reported, including the previously mentioned sirtuins
and AMPK. Activation of these proteins is associated with increased
mitochondria activity. In contrast, impairment of another nutrient-
sensing pathway, mTOR (mammalian target of rapamycin), was
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metabolism [127,128]. Consistently, the translational inhibitor 4E-BP,
which is repressed by TOR, regulates mitochondrial activity in CR ﬂies
[129]. Furthermore, TOR signaling has been shown to be regulated by
AMPK, suggesting that both nutrient-sensing pathways are located
upstream of mitochondria function, thereby representing key regu-
lators of mitochondrial metabolism [130].
Taken together, there are numerous studies linking mitochondrial
activity with prolongation of life expectancy, suggesting that a meta-
bolic switch to oxidative metabolism seems to be beneﬁcial in regard
to delay aging and the onset of age-related diseases.
Oxidative stress and mitochondrial hormesis (mitohormesis)
Increased ROS formation as a consequence of increased metabolic
rate has been postulated to be the major determinant of life span [11].
Becausemitochondria are an intracellular source of ROS, the theorywas
extended to the mitochondrial free radical theory [131], without the
knowledge that meanwhile the fact that increased metabolic rate does
not necessarily result in increased ROS formation had been established.
Thus, signiﬁcant research has been done to prove this hypothesis with
inconsistent and partly contradictive results [132]. However, a
considerable number of ﬁndings in various organisms suggest that
reduction of oxidative stress is associated with prolongation of life
expectancy [133–147]. Consequently, ROS-lowering interventions
were widely proposed as an antiaging strategy in humans. Antioxi-
dants, a group of synthetic or naturally occurring substances, which are
capable of scavenging free radicals, were extensively examined in that
regard. Unexpectedly and in contrast to some of the above-mentioned
work in lower organisms, several prospective clinical intervention
studies were unable to show a positive association between supple-
mentation with antioxidants and health-beneﬁcial effects. Whereas
most studies found a lack of effect in regards to health promotion in
humans [148–162], other reports even suggest that antioxidants may
promote cancer growth [163–168]. Moreover, supplementation with
antioxidants has been linked to increased incidence of a number of
diseases with adverse effects on human longevity [169–175].
Not surprisingly, these ﬁndings question Harman's FRTA and
require a different point of view concerning the role of mitochondrial
ROS formation. Accordingly, numerous ﬁndings have emerged in
recent years indicating that ROS may evoke cellular signaling that
promotes metabolic health and longevity. It has been assumed that
they serve as essential signaling molecules delivering messages
from the mitochondria to other cellular compartments in response
to physiological or pathophysiological changes [23,176–190]. More-
over, and given the increased levels of oxidative damage during
increasing age, intrinsic aging may be considered an insufﬁcient
ability to respond to endogenous ROS signals.
Interestingly, exposure of C. elegans to hyperbaric conditions
results in stress resistance and prolongation of life expectancy,
whereas such conditions cause an increase in mitochondrial ROS
formation [191–194]. Hypothermia, a state that is associated with
extend life span in mice and C. elegans [195,196], has been recently
shown to induce mitochondrial ROS production as well [197]. More-
over, it was shown that CR also induces low-level stress leading to
the same adaptive processes, such as increased stress resistance and
longevity [21,26,198–200].
These ﬁndings insinuate that so-called adaptive response process-
es may explain how increased ROS formation culminates in
promotion of health and life span. Interestingly, low doses of ROS
seem to exert such effects, whereas higher doses are unquestionably
detrimental. Such biphasic responses to a potentially harmful com-
pound are commonly named hormesis, a concept that was initially
postulated in 1943 by Southam and Ehrlich and which was shown to
have signiﬁcant impact on aging with a variety of stressors described
[201–205]. Later, this term was extended to mitochondrial hormesisor mitohormesis, with regard to mitochondrial ROS as a hypotheti-
cally sublethal stressor [206].
In agreement with this concept, it has been frequently reported
that rodents exposed to CR exhibit elevated antioxidant defense
capacities [15–20,207]. Furthermore, life-extending glucose restric-
tion in yeast was shown to be accompanied by a decrease in ROS
production, whereas respiration was enhanced [22]. On the other
hand and in conﬂict with these data, it was also reported that
the same intervention in the same model organism increases
ROS production as well as respiration [23–25,43,208,209]. Moreover,
antioxidant enzyme activity was found to be elevated as well
[24,43,208,209], suggesting a potential involvement of increased
respiration, enhanced ROS formation, and the induction of ROS
defense mechanisms in regard to regulation of longevity.
Consistently, numerous studies using various model organisms
were unable to ﬁnd any evidence to support that lowering ROS is
beneﬁcial in regard to longevity, nor that increasing antioxidant
capacity extends life span [210–227]. Moreover, life-span-extending
mutations in C. elegans are commonly accompanied by increased
stress resistance and sometimes paralleled by enhanced metabolic
activity [228–233]. Furthermore, in the ﬁeld of neuroprotective
research, similar hormetic results were achieved with CR as well as
DOG application in rodents [234]. Depletion of mitochondrial NADH
kinase, an enzyme crucial for antioxidant defense, causes life-span
extension and DNA stability due to adaptivemechanisms in Podospora
anserine [235]. Finally, human subjects on a carbohydrate-depleted
diet (i.e., a ketogenic diet) show improved ROS defense capacity
presumably due to elevated oxidative metabolism [236].
Taken together, all these ﬁndings provide indirect evidences
for the hypothesis that ROS production and subsequent induction of
ROS defense are essential contributors to longevity. To prove this
hypothesis, the previously described inhibitor of glycolysis, DOG, was
applied to C. elegans, resulting in a decrease in glucose availability
followed by a compensatory increase in respiration [23]. The increase
in oxygen consumption was associated with an increase in ROS
formation and a consequent induction of antioxidant enzyme activity,
ﬁnally leading to life-span extension [23]. Most importantly, simul-
taneous treatment with various antioxidants completely abolished
this life-span-extending effect of DOG, suggesting that an increase in
ROS formation is essential for CR-induced promotion of longevity [23].
These ﬁndings were corroborated by very recent studies that
examine the effect of CR in S. cerevisiae and Schizosaccharomyces
pombe [24,25,27]. Correspondingly, an increased mitochondrial
respiration and/or a subsequent enhanced ROS production after CR
were observed [24,25,27]. Hence, similar to the above-mentioned
observations in C. elegans, activation of stress response pathways as
well as induction of defense mechanisms has been discussed as
representing the underlying life-span-extending mechanisms
[24,25,27,188–190]. It should be noted that endogenously produced
ROS presumably not only induce ROS defense enzymes, but also
increase activities of phase II response enzymes that protect from
damage beyond ROS. On a hypothetical basis this would explain the
clearly opposite effects of supplementation with exogenous antiox-
idants and/or genetic overexpression of antioxidant enzymes, on the
one hand, and endogenous response to endogenous ROS production
on the other hand. Future research will also have to investigate
whether response mechanisms to stressors such as endogenous ROS
may be less likely to be activated at higher age.
Physical exercise
Consistent with the concept of mitohormesis, glucose restriction
leads to an increase in mitochondrial activity accompanied by an
increase in respiration-derived ROS formation that serves as a
mild stressor (Fig. 1). This ROS signal is able to induce conserved
downstream processes (such as activation of speciﬁc oxidative stress-
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Fig. 1. Life-span-extending interventions generate mitochondrial ROS signals to activate longevity-promoting genes. For calorie and especially glucose restriction, but also for
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factors) that culminate in an overall adaptive response, represented
by an improvement in antioxidant capacity and ﬁnally longevity.
Cotreatment with antioxidants inhibits ROS signal transduction and
prevents the adaptive response. Thus, glucose-restriction-mediated
longevity is abolished.
Therefore, interventions that induce mitochondrial function seem
to be promising in regard to regulation of life expectancy. Accordingly,
moderate physical activity, an intervention that is known to be health
beneﬁcial in a broad spectrum [120,121,237–239], is assumed to
cause induction of mitochondrial metabolism and ROS production
[240–242]. Moreover, health-promoting effects were demonstrated to
be reduced if subjects exposed to physical activity were cotreated
with antioxidant supplements [186,243].
Conclusions
Taken together, the data summarized and discussed in this review
support the conclusion that CR, glucose restriction, and moderate
physical activity share, at least in part, common mechanistic features
that may inﬂuence the aging process, i.e., enhanced mitochondrial
activity and subsequently increased ROS formation that ultimately
induce an adaptive response (increased defense mechanisms and
improved stress resistance), which culminates in metabolic health
and extended longevity.
Acknowledgments
Studies in the authors’ laboratory are or have been supported by
the German Research Association, the German Ministry of Educationand Research (in particular the Jena Center for Systems Biology of
Ageing, Support Code 0315581), and the European Foundation for the
Study of Diabetes. We apologize to those whose work relevant to the
topic was not cited solely because of space limitations.
References
[1] McCay, C. M.; Crowel, M. F.; Maynard, L. A. The effect of retarded growth upon
the length of the life span and upon ultimate body size. J. Nutr. 10:63–79; 1935.
[2] Fontana, L.; Partridge, L.; Longo, V. D. Extending healthy life span—from yeast to
humans. Science 328:321–326; 2010.
[3] Fontana, L.; Meyer, T. E.; Klein, S.; Holloszy, J. O. Long-term calorie restriction is
highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl
Acad. Sci. U. S. A. 101:6659–6663; 2004.
[4] Heilbronn, L. K.; de Jonge, L.; Frisard,M. I.; DeLany, J. P.; Larson-Meyer, D. E.; Rood,
J.; Nguyen, T.;Martin, C. K.; Volaufova, J.;Most,M.M.; Greenway, F. L.; Smith, S. R.;
Deutsch, W. A.; Williamson, D. A.; Ravussin, E. Effect of 6-month calorie
restriction on biomarkers of longevity, metabolic adaptation, and oxidative
stress in overweight individuals: a randomized controlled trial. JAMA 295:
1539–1548; 2006.
[5] Fontana, L.; Klein, S. Aging, adiposity, and calorie restriction. JAMA 297:986–994;
2007.
[6] Colman, R. J.; Anderson, R.M.; Johnson, S. C.; Kastman, E. K.; Kosmatka, K. J.; Beasley,
T.M.; Allison,D. B.; Cruzen, C.; Simmons,H. A.; Kemnitz, J.W.;Weindruch, R. Caloric
restriction delays disease onset and mortality in rhesus monkeys. Science 325:
201–204; 2009.
[7] Ingram, D. K.; Roth, G. S.; Lane, M. A.; Ottinger, M. A.; Zou, S.; de Cabo, R.;
Mattison, J. A. The potential for dietary restriction to increase longevity in
humans: extrapolation from monkey studies. Biogerontology 7:143–148; 2006.
[8] Weindruch, R. Will dietary restriction work in primates? Biogerontology 7:
169–171; 2006.
[9] Rubner, M. III. Das Wachstumsproblem und die Lebensdauer des Menschen und
einiger Säugetiere vom energetischen Standpunkt aus betrachtet. In: Rubner, M.
(Ed.), Das Problem der Lebensdauer und seine Beziehungen zumWachstum und
der Ernährung. Oldenbourg, Munich/Berlin,pp. 127–208; 1908.
[10] Pearl, R. The Rate of Living: being an account of some experimental studies on
the biology of life duration. Knopf, New York; 1928.
332 M. Ristow, S. Schmeisser / Free Radical Biology & Medicine 51 (2011) 327–336[11] Harman, D. Aging: a theory based on free radical and radiation chemistry. J.
Gerontol. 11:298–300; 1956.
[12] Harman, D. Origin and evolution of the free radical theory of aging: a brief
personal history, 1954–2009. Biogerontology 10:773–781; 2009.
[13] Houthoofd, K.; Braeckman, B. P.; Lenaerts, I.; Brys, K.; De Vreese, A.; Van Eygen,
S.; Vanﬂeteren, J. R. Axenic growth up-regulates mass-speciﬁc metabolic rate,
stress resistance, and extends life span in Caenorhabditis elegans. Exp. Gerontol.
37:1371–1378; 2002.
[14] Hulbert, A. J.; Clancy, D. J.; Mair, W.; Braeckman, B. P.; Gems, D.; Partridge, L.
Metabolic rate is not reduced by dietary-restriction or by lowered insulin/IGF-1
signalling and is not correlated with individual lifespan in Drosophila
melanogaster. Exp. Gerontol. 39:1137–1143; 2004.
[15] Koizumi, A.; Weindruch, R.; Walford, R. L. Inﬂuences of dietary restriction and
age on liver enzyme activities and lipid peroxidation in mice. J. Nutr. 117:
361–367; 1987.
[16] Semsei, I.; Rao, G.; Richardson, A. Changes in the expression of superoxide
dismutase and catalase as a function of age and dietary restriction. Biochem.
Biophys. Res. Commun. 164:620–625; 1989.
[17] Rao, G.; Xia, E.; Nadakavukaren, M. J.; Richardson, A. Effect of dietary restriction
on the age-dependent changes in the expression of antioxidant enzymes in rat
liver. J. Nutr. 120:602–609; 1990.
[18] Pieri, C.; Falasca, M.; Marcheselli, F.; Moroni, F.; Recchioni, R.; Marmocchi, F.;
Lupidi, G. Food restriction in female Wistar rats. V. Lipid peroxidation and
antioxidant enzymes in the liver. Arch. Gerontol. Geriatr. 14:93–99; 1992.
[19] Youngman, L. D.; Park, J. Y.; Ames, B. N. Protein oxidation associated with aging is
reduced by dietary restriction of protein or calories. Proc. Natl Acad. Sci. U. S. A.
89:9112–9116; 1992.
[20] Xia, E.; Rao, G.; Van Remmen, H.; Heydari, A. R.; Richardson, A. Activities of
antioxidant enzymes in various tissues of male Fischer 344 rats are altered by
food restriction. J. Nutr. 125:195–201; 1995.
[21] Masoro, E. J. Hormesis and the antiaging action of dietary restriction. Exp.
Gerontol. 33:61–66; 1998.
[22] Barros, M. H.; Bandy, B.; Tahara, E. B.; Kowaltowski, A. J. Higher respiratory
activity decreases mitochondrial reactive oxygen release and increases life span
in Saccharomyces cerevisiae. J. Biol. Chem. 279:49883–49888; 2004.
[23] Schulz, T. J.; Zarse, K.; Voigt, A.; Urban, N.; Birringer, M.; Ristow, M. Glucose
restriction extends Caenorhabditis elegans life span by inducing mitochondrial
respiration and increasing oxidative stress. Cell Metab. 6:280–293; 2007.
[24] Sharma, P. K.; Agrawal, V.; Roy, N. Mitochondria-mediated hormetic response in
life span extension of calorie-restricted Saccharomyces cerevisiae. Age 33:
143–154; 2010.
[25] Zuin, A.; Carmona, M.; Morales-Ivorra, I.; Gabrielli, N.; Vivancos, A. P.; Ayte, J.;
Hidalgo, E. Lifespan extension by calorie restriction relies on the Sty1MAP kinase
stress pathway. EMBO J. 29:981–991; 2010.
[26] Rattan, S. I.; Demirovic, D. Hormesis as a mechanism for the anti-aging effects of
calorie restriction. In: Everitt, A.V., Rattan, S.I.S., Couteur, D.G., Cabo, R.D. (Eds.),
Calorie Restriction, Aging and Longevity. Springer Netherlands, Dordrecht,
pp. 233–245; 2010.
[27] Mesquita, A.; Weinberger, M.; Silva, A.; Sampaio-Marques, B.; Almeida, B.; Leao,
C.; Costa, V.; Rodrigues, F.; Burhans, W. C.; Ludovico, P. Caloric restriction or
catalase inactivation extends yeast chronological lifespan by inducing H2O2 and
superoxide dismutase activity. Proc. Natl Acad. Sci. U. S. A. 107:15123–15128;
2010.
[28] Iwasaki, K.; Gleiser, C. A.; Masoro, E. J.; McMahan, C. A.; Seo, E. J.; Yu, B. P.
Inﬂuence of the restriction of individual dietary components on longevity and
age-related disease of Fischer rats: the fat component and the mineral
component. J. Gerontol. 43:B13–B21; 1988.
[29] Stoltzner, G. Effects of life-long dietary protein restriction on mortality, growth,
organ weights, blood counts, liver aldolase and kidney catalase in Balb/C mice.
Growth 41:337–348; 1977.
[30] Leto, S.; Kokkonen, G. C.; Barrows Jr., C. H. Dietary protein, life-span, and
biochemical variables in female mice. J. Gerontol. 31:144–148; 1976.
[31] Fernandes, G.; Yunis, E. J.; Good, R. A. Inﬂuence of diet on survival of mice. Proc.
Natl Acad. Sci. U. S. A. 73:1279–1283; 1976.
[32] Min, K. J.; Tatar, M. Restriction of amino acids extends lifespan in Drosophila
melanogaster. Mech. Ageing Dev. 127:643–646; 2006.
[33] Grandison, R. C.; Piper, M. D.; Partridge, L. Amino-acid imbalance explains
extension of lifespan by dietary restriction in Drosophila. Nature 462:
1061–1064; 2009.
[34] Zimmerman, J. A.; Malloy, V.; Krajcik, R.; Orentreich, N. Nutritional control of
aging. Exp. Gerontol. 38:47–52; 2003.
[35] Miller, R. A.; Buehner, G.; Chang, Y.; Harper, J. M.; Sigler, R.; Smith-Wheelock, M.
Methionine-deﬁcient diet extends mouse lifespan, slows immune and lens
aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF
levels and stress resistance. Aging Cell 4:119–125; 2005.
[36] Perrone, C. E.; Mattocks, D. A.; Jarvis-Morar, M.; Plummer, J. D.; Orentreich, N.
Methionine restriction effects on mitochondrial biogenesis and aerobic capacity
in white adipose tissue, liver, and skeletal muscle of F344 rats. Metabolism 59:
1000–1011; 2010.
[37] De, A. K.; Chipalkatti, S.; Aiyar, A. S. Some biochemical parameters of ageing in
relation to dietary protein. Mech. Ageing Dev. 21:37–48; 1983.
[38] Meissner, B.; Boll, M.; Daniel, H.; Baumeister, R. Deletion of the intestinal peptide
transporter affects insulin and TOR signaling in Caenorhabditis elegans. J. Biol.
Chem. 279:36739–36745; 2004.
[39] Mair, W.; Piper, M. D.; Partridge, L. Calories do not explain extension of life span
by dietary restriction in Drosophila. PLoS Biol. 3:e223; 2005.[40] Lin, S. J.; Kaeberlein, M.; Andalis, A. A.; Sturtz, L. A.; Defossez, P. A.; Culotta, V. C.;
Fink, G. R.; Guarente, L. Calorie restriction extends Saccharomyces cerevisiae
lifespan by increasing respiration. Nature 418:344–348; 2002.
[41] Lin, S. J.; Defossez, P. A.; Guarente, L. Requirement of NAD and SIR2 for life-span
extension by calorie restriction in Saccharomyces cerevisiae. Science 289:
2126–2128; 2000.
[42] Kaeberlein, M.; Kirkland, K. T.; Fields, S.; Kennedy, B. K. Sir2-independent life
span extension by calorie restriction in yeast. PLoS Biol. 2:E296; 2004.
[43] Agarwal, S.; Sharma, S.; Agrawal, V.; Roy, N. Caloric restriction augments ROS
defense in S. cerevisiae by a Sir2p independent mechanism. Free Radic. Res. 39:
55–62; 2005.
[44] Guarente, L.; Picard, F. Calorie restriction—the SIR2 connection. Cell 120:
473–482; 2005.
[45] Smith Jr., D. L.; McClure, J. M.; Matecic, M.; Smith, J. S. Calorie restriction extends
the chronological lifespan of Saccharomyces cerevisiae independently of the
sirtuins. Aging Cell 6:649–662; 2007.
[46] Roux, A. E.; Leroux, A.; Alaamery, M. A.; Hoffman, C. S.; Chartrand, P.; Ferbeyre,
G.; Rokeach, L. A. Pro-aging effects of glucose signaling through a G protein-
coupled glucose receptor in ﬁssion yeast. PLoS Genet. 5:e1000408; 2009.
[47] Wick, A. N.; Drury, D. R.; Nakada, H. I.; Wolfe, J. B. Localization of the primary
metabolic block produced by 2-deoxyglucose. J. Biol. Chem. 224:963–969; 1957.
[48] Sols, A.; Crane, R. K. Substrate speciﬁcity of brain hexokinase. J. Biol. Chem. 210:
581–595; 1954.
[49] Garriga-Canut, M.; Schoenike, B.; Qazi, R.; Bergendahl, K.; Daley, T. J.; Pfender, R.
M.; Morrison, J. F.; Ockuly, J.; Stafstrom, C.; Sutula, T.; Roopra, A. 2-Deoxy-D-
glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic
regulation of chromatin structure. Nat. Neurosci. 9:1382–1387; 2006.
[50] Lane, M. A.; Ingram, D. K.; Roth, G. S. 2-Deoxy-D-glucose feeding in rats mimics
physiologic effects of calorie restriction. J. Anti Aging Med. 1:327–336; 1998.
[51] Ingram, D. K.; Anson, R. M.; de Cabo, R.; Mamczarz, J.; Zhu, M.; Mattison, J.; Lane,
M. A.; Roth, G. S. Development of calorie restriction mimetics as a prolongevity
strategy. Ann. N. Y. Acad. Sci. 1019:412–423; 2004.
[52] Duan, W.; Mattson, M. P. Dietary restriction and 2-deoxyglucose administration
improve behavioral outcome and reduce degeneration of dopaminergic neurons
in models of Parkinson's disease. J. Neurosci. Res. 57:195–206; 1999.
[53] Sinclair, D. A. Toward a uniﬁed theory of caloric restriction and longevity
regulation. Mech. Ageing Dev. 126:987–1002; 2005.
[54] Zhu, Z.; Jiang, W.; McGinley, J. N.; Thompson, H. J. 2-Deoxyglucose as an energy
restrictionmimetic agent: effects onmammary carcinogenesis and onmammary
tumor cell growth in vitro. Cancer Res. 65:7023–7030; 2005.
[55] Ingram, D. K.; Zhu, M.; Mamczarz, J.; Zou, S.; Lane, M. A.; Roth, G. S.; deCabo, R.
Calorie restriction mimetics: an emerging research ﬁeld. Aging Cell 5:97–108;
2006.
[56] Minor, R. K.; Smith Jr., D. L.; Sossong, A. M.; Kaushik, S.; Poosala, S.; Spangler, E. L.;
Roth, G. S.; Lane, M.; Allison, D. B.; de Cabo, R.; Ingram, D. K.; Mattison, J. A.
Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and
increases mortality in rats. Toxicol. Appl. Pharmacol. 243:332–339; 2010.
[57] Hardie, D. G.; Hawley, S. A.; Scott, J. W. AMP-activated protein kinase:
development of the energy sensor concept. J. Physiol. 574:7–15; 2006.
[58] Apfeld, J.; O'Connor, G.; McDonagh, T.; DiStefano, P. S.; Curtis, R. The AMP-
activated protein kinase aak-2 links energy levels and insulin-like signals to
lifespan in C. elegans. Genes Dev. 18:3004–3009; 2004.
[59] Greer, E. L.; Dowlatshahi, D.; Banko, M. R.; Villen, J.; Hoang, K.; Blanchard, D.;
Gygi, S. P.; Brunet, A. An AMPK–FOXO pathway mediates longevity induced by a
novel method of dietary restriction in C. elegans. Curr. Biol. 17:1646–1656; 2007.
[60] Pan, D. A.; Hardie, D. G. A homologue of AMP-activated protein kinase in
Drosophila melanogaster is sensitive to AMP and is activated by ATP depletion.
Biochem. J. 367:179–186; 2002.
[61] Onken, B.; Driscoll, M. Metformin induces a dietary restriction-like state and the
oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and
SKN-1. PLoS One 5:e8758; 2010.
[62] Kotani, K.; Peroni, O. D.; Minokoshi, Y.; Boss, O.; Kahn, B. B. GLUT4 glucose
transporter deﬁciency increases hepatic lipid production and peripheral lipid
utilization. J. Clin. Invest. 114:1666–1675; 2004.
[63] McCarter, R.; Mejia, W.; Ikeno, Y.; Monnier, V.; Kewitt, K.; Gibbs, M.; McMahan,
A.; Strong, R. Plasma glucose and the action of calorie restriction on aging. J.
Gerontol. A Biol. Sci. Med. Sci. 62:1059–1070; 2007.
[64] Lee, S. J.; Murphy, C. T.; Kenyon, C. Glucose shortens the life span of C. elegans by
downregulating DAF-16/FOXO activity and aquaporin gene expression. Cell
Metab. 10:379–391; 2009.
[65] Schlotterer, A.; Kukudov, G.; Bozorgmehr, F.; Hutter, H.; Du, X.; Oikonomou, D.;
Ibrahim, Y.; Pﬁsterer, F.; Rabbani, N.; Thornalley, P.; Sayed, A.; Fleming, T.;
Humpert, P.; Schwenger, V.; Zeier, M.; Hamann, A.; Stern, D.; Brownlee, M.;
Bierhaus, A.; Nawroth, P.; Morcos, M. C. elegans as model for the study of high
glucose mediated lifespan reduction. Diabetes 58:2450–2456; 2009.
[66] Nordmann, A. J.; Nordmann, A.; Briel, M.; Keller, U.; Yancy Jr., W. S.; Brehm, B. J.;
Bucher, H. C. Effects of low-carbohydrate vs low-fat diets on weight loss and
cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch.
Intern. Med. 166:285–293; 2006.
[67] Hession, M.; Rolland, C.; Kulkarni, U.; Wise, A.; Broom, J. Systematic review of
randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in
the management of obesity and its comorbidities. Obes. Rev. 10:36–50; 2009.
[68] Volek, J. S.; Phinney, S. D.; Forsythe, C. E.; Quann, E. E.; Wood, R. J.; Puglisi, M. J.;
Kraemer, W. J.; Bibus, D. M.; Fernandez, M. L.; Feinman, R. D. Carbohydrate
restriction has a more favorable impact on the metabolic syndrome than a low
fat diet. Lipids 44:297–309; 2009.
333M. Ristow, S. Schmeisser / Free Radical Biology & Medicine 51 (2011) 327–336[69] Forsythe, C. E.; Phinney, S. D.; Fernandez, M. L.; Quann, E. E.; Wood, R. J.; Bibus, D.
M.; Kraemer, W. J.; Feinman, R. D.; Volek, J. S. Comparison of low fat and low
carbohydrate diets on circulating fatty acid composition and markers of
inﬂammation. Lipids 43:65–77; 2008.
[70] Quarrie, J. K.; Riabowol, K. T. Murine models of life span extension. Sci. Aging
Knowledge Environ. 2004:re5; 2004.
[71] Brown-Borg, H. M.; Borg, K. E.; Meliska, C. J.; Bartke, A. Dwarf mice and the
ageing process. Nature 384:33; 1996.
[72] Pendergrass, W. R.; Li, Y.; Jiang, D.; Wolf, N. S. Decrease in cellular replicative
potential in "giant" mice transfected with the bovine growth hormone gene
correlates to shortened life span. J. Cell. Physiol. 156:96–103; 1993.
[73] Steger, R. W.; Bartke, A.; Cecim, M. Premature ageing in transgenic mice
expressing different growth hormone genes. J. Reprod. Fertil. Suppl. 46:61–75;
1993.
[74] Holzenberger, M.; Dupont, J.; Ducos, B.; Leneuve, P.; Geloen, A.; Even, P. C.;
Cervera, P.; Le Bouc, Y. IGF-1 receptor regulates lifespan and resistance to
oxidative stress in mice. Nature 421:182–187; 2003.
[75] Kappeler, L.; De Magalhaes Filho, C. M.; Dupont, J.; Leneuve, P.; Cervera, P.; Perin,
L.; Loudes, C.; Blaise, A.; Klein, R.; Epelbaum, J.; Le Bouc, Y.; Holzenberger, M.
Brain IGF-1 receptors control mammalian growth and lifespan through a
neuroendocrine mechanism. PLoS Biol. 6:e254; 2008.
[76] Bitto, A.; Lerner, C.; Torres, C.; Roell, M.; Malaguti, M.; Perez, V.; Lorenzini, A.;
Hrelia, S.; Ikeno, Y.; Matzko, M. E.; McCarter, R.; Sell, C. Long-term Igf-I exposure
decreases autophagy and cell viability. PLoS One 5:e12592; 2010.
[77] Kahn, C. R. Insulin action, diabetogenes, and the cause of type II diabetes.
Diabetes 43:1066–1084; 1994.
[78] Biddinger, S. B.; Kahn, C. R. Frommice to men: insights into the insulin resistance
syndromes. Annu. Rev. Physiol. 68:123–158; 2006.
[79] Brüning, J. C.; Michael, M. D.; Winnay, J. N.; Hayashi, T.; Hörsch, D.; Accili, D.;
Goodyear, L. J.; Kahn, C. R. A muscle-speciﬁc insulin receptor knockout exhibits
features of the metabolic syndrome of NIDDM without altering glucose
tolerance. Mol. Cell 2:559–569; 1998.
[80] Blüher, M.; Kahn, B. B.; Kahn, C. R. Extended longevity in mice lacking the insulin
receptor in adipose tissue. Science 299:572–574; 2003.
[81] Selman, C.; Lingard, S.; Choudhury, A. I.; Batterham, R. L.; Claret, M.; Clements, M.;
Ramadani, F.; Okkenhaug, K.; Schuster, E.; Blanc, E.; Piper, M. D.; Al-Qassab, H.;
Speakman, J. R.; Carmignac, D.; Robinson, I. C.; Thornton, J. M.; Gems, D.; Partridge,
L.; Withers, D. J. Evidence for lifespan extension and delayed age-related
biomarkers in insulin receptor substrate 1 null mice. FASEB J. 22:807–818; 2008.
[82] Taguchi, A.; Wartschow, L. M.; White, M. F. Brain IRS2 signaling coordinates life
span and nutrient homeostasis. Science 317:369–372; 2007.
[83] Friedman, D. B.; Johnson, T. E. A mutation in the age-1 gene in Caenorhabditis
elegans lengthens life and reduces hermaphrodite fertility. Genetics 118:75–86;
1988.
[84] Kenyon, C.; Chang, J.; Gensch, E.; Rudner, A.; Tabtiang, R. A C. elegansmutant that
lives twice as long as wild type. Nature 366:461–464; 1993.
[85] Kimura, K. D.; Tissenbaum, H. A.; Liu, Y.; Ruvkun, G. daf-2, an insulin receptor-
like gene that regulates longevity and diapause in Caenorhabditis elegans.
Science 277:942–946; 1997.
[86] Clancy, D. J.; Gems, D.; Harshman, L. G.; Oldham, S.; Stocker, H.; Hafen, E.;
Leevers, S. J.; Partridge, L. Extension of life-span by loss of CHICO, a Drosophila
insulin receptor substrate protein. Science 292:104–106; 2001.
[87] Tatar, M.; Kopelman, A.; Epstein, D.; Tu, M. P.; Yin, C. M.; Garofalo, R. S. A mutant
Drosophila insulin receptor homolog that extends life-span and impairs
neuroendocrine function. Science 292:107–110; 2001.
[88] Brys, K.; Castelein, N.; Matthijssens, F.; Vanﬂeteren, J. R.; Braeckman, B. P.
Disruption of insulin signalling preserves bioenergetic competence of mito-
chondria in ageing Caenorhabditis elegans. BMC Biol. 8:91; 2010.
[89] van Heemst, D.; Beekman, M.; Mooijaart, S. P.; Heijmans, B. T.; Brandt, B. W.;
Zwaan, B. J.; Slagboom, P. E.; Westendorp, R. G. Reduced insulin/IGF-1 signalling
and human longevity. Aging Cell 4:79–85; 2005.
[90] Pawlikowska, L.; Hu, D.; Huntsman, S.; Sung, A.; Chu, C.; Chen, J.; Joyner, A.;
Schork, N. J.; Hsueh, W. C.; Reiner, A. P.; Psaty, B. M.; Atzmon, G.; Barzilai, N.;
Cummings, S. R.; Browner, W. S.; Kwok, P. Y.; Ziv, E. Association of common
genetic variation in the insulin/IGF1 signaling pathway with human longevity.
Aging Cell 8:460–472; 2009.
[91] Lakowski, B.; Hekimi, S. The genetics of caloric restriction in Caenorhabditis
elegans. Proc. Natl Acad. Sci. U. S. A. 95:13091–13096; 1998.
[92] Bartke, A.; Masternak, M.M.; Al-Regaiey, K. A.; Bonkowski, M. S. Effects of dietary
restriction on the expression of insulin-signaling-related genes in long-lived
mutant mice. Interdiscip. Top. Gerontol. 35:69–82; 2007.
[93] Houthoofd, K.; Braeckman, B. P.; Johnson, T. E.; Vanﬂeteren, J. R. Life extension
via dietary restriction is independent of the Ins/IGF-1 signalling pathway in
Caenorhabditis elegans. Exp. Gerontol. 38:947–954; 2003.
[94] Min, K. J.; Yamamoto, R.; Buch, S.; Pankratz, M.; Tatar, M. Drosophila lifespan
control by dietary restriction independent of insulin-like signaling. Aging Cell 7:
199–206; 2008.
[95] Bonkowski, M. S.; Dominici, F. P.; Arum, O.; Rocha, J. S.; Al Regaiey, K. A.;
Westbrook, R.; Spong, A.; Panici, J.; Masternak, M. M.; Kopchick, J. J.; Bartke, A.
Disruption of growth hormone receptor prevents calorie restriction from
improving insulin action and longevity. PLoS One 4:e4567; 2009.
[96] Brown-Borg, H. M.; Rakoczy, S. G.; Romanick, M. A.; Kennedy, M. A. Effects of
growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative
enzymes. Exp. Biol. Med. (Maywood) 227:94–104; 2002.
[97] Clancy, D. J.; Gems, D.; Hafen, E.; Leevers, S. J.; Partridge, L. Dietary restriction in
long-lived dwarf ﬂies. Science 296:319; 2002.[98] Al-Regaiey, K. A.; Masternak, M. M.; Bonkowski, M.; Sun, L.; Bartke, A. Long-lived
growth hormone receptor knockout mice: interaction of reduced insulin-like
growth factor I/insulin signaling and caloric restriction. Endocrinology 146:
851–860; 2005.
[99] Bonkowski, M. S.; Rocha, J. S.; Masternak, M. M.; Al Regaiey, K. A.; Bartke, A.
Targeted disruption of growth hormone receptor interferes with the beneﬁcial
actions of calorie restriction. Proc. Natl Acad. Sci. U. S. A. 103:7901–7905; 2006.
[100] Narasimhan, S. D.; Yen, K.; Tissenbaum, H. A. Converging pathways in lifespan
regulation. Curr. Biol. 19:R657–R666; 2009.
[101] Yen, K.; Mobbs, C. V. Evidence for only two independent pathways for decreasing
senescence in Caenorhabditis elegans. Age (Dordrecht) 32:39–49; 2010.
[102] Yechoor, V. K.; Patti, M. E.; Ueki, K.; Laustsen, P. G.; Saccone, R.; Rauniyar, R.;
Kahn, C. R. Distinct pathways of insulin-regulated versus diabetes-regulated
gene expression: an in vivo analysis in MIRKO mice. Proc. Natl Acad. Sci. U. S. A.
101:16525–16530; 2004.
[103] Brooks, N. L.; Trent, C. M.; Raetzsch, C. F.; Flurkey, K.; Boysen, G.; Perfetti, M. T.;
Jeong, Y. C.; Klebanov, S.; Patel, K. B.; Khodush, V. R.; Kupper, L. L.; Carling, D.;
Swenberg, J. A.; Harrison, D. E.; Combs, T. P. Low utilization of circulating
glucose after food withdrawal in Snell dwarf mice. J. Biol. Chem. 282:
35069–35077; 2007.
[104] Katic, M.; Kennedy, A. R.; Leykin, I.; Norris, A.; McGettrick, A.; Gesta, S.; Russell, S.
J.; Bluher, M.; Maratos-Flier, E.; Kahn, C. R. Mitochondrial gene expression and
increased oxidative metabolism: role in increased lifespan of fat-speciﬁc insulin
receptor knock-out mice. Aging Cell 6:827–839; 2007.
[105] Russell, S. J.; Kahn, C. R. Endocrine regulation of ageing. Nat. Rev. Mol. Cell Biol. 8:
681–691; 2007.
[106] Westbrook, R.; Bonkowski, M. S.; Strader, A. D.; Bartke, A. Alterations in oxygen
consumption, respiratory quotient, and heat production in long-lived GHRKO
and Ames dwarf mice, and short-lived bGH transgenic mice. J. Gerontol. A Biol. Sci.
Med. Sci. 64:443–451; 2009.
[107] Wiederkehr, A.; Wollheim, C. B. Implication of mitochondria in insulin secretion
and action. Endocrinology 147:2643–2649; 2006.
[108] Ristow, M. Oxidative metabolism in cancer growth. Curr. Opin. Clin. Nutr. Metab.
9:339–345; 2006.
[109] Fukui, H.; Moraes, C. T. The mitochondrial impairment, oxidative stress and
neurodegeneration connection: reality or just an attractive hypothesis? Trends
Neurosci. 31:251–256; 2008.
[110] Tatsuta, T.; Langer, T. Quality control of mitochondria: protection against
neurodegeneration and ageing. EMBO J. 27:306–314; 2008.
[111] Trifunovic, A.; Larsson, N. G. Mitochondrial dysfunction as a cause of ageing. J.
Intern. Med. 263:167–178; 2008.
[112] Bratic, I.; Trifunovic, A. Mitochondrial energy metabolism and ageing. Biochim.
Biophys. Acta 1797:961–967; 2010.
[113] Masoro, E. J.; Yu, B. P.; Bertrand, H. A. Action of food restriction in delaying the
aging process. Proc. Natl Acad. Sci. U. S. A. 79:4239–4241; 1982.
[114] Nisoli, E.; Tonello, C.; Cardile, A.; Cozzi, V.; Bracale, R.; Tedesco, L.; Falcone, S.;
Valerio, A.; Cantoni, O.; Clementi, E.; Moncada, S.; Carruba, M. O. Calorie
restriction promotes mitochondrial biogenesis by inducing the expression of
eNOS. Science 310:314–317; 2005.
[115] Lopez-Lluch, G.; Hunt, N.; Jones, B.; Zhu, M.; Jamieson, H.; Hilmer, S.; Cascajo, M.
V.; Allard, J.; Ingram, D. K.; Navas, P.; de Cabo, R. Calorie restriction induces
mitochondrial biogenesis and bioenergetic efﬁciency. Proc. Natl Acad. Sci. U. S. A.
103:1768–1773; 2006.
[116] Selman, C.; Phillips, T.; Staib, J. L.; Duncan, J. S.; Leeuwenburgh, C.; Speakman, J. R.
Energy expenditure of calorically restricted rats is higher than predicted from
their altered body composition. Mech. Ageing Dev. 126:783–793; 2005.
[117] Alvers, A. L.; Fishwick, L. K.; Wood, M. S.; Hu, D.; Chung, H. S.; Dunn Jr., W. A.;
Aris, J. P. Autophagy and amino acid homeostasis are required for chronological
longevity in Saccharomyces cerevisiae. Aging Cell 8:353–369; 2009.
[118] D'Antona, G.; Ragni, M.; Cardile, A.; Tedesco, L.; Dossena, M.; Bruttini, F.; Caliaro,
F.; Corsetti, G.; Bottinelli, R.; Carruba, M. O.; Valerio, A.; Nisoli, E. Branched-chain
amino acid supplementation promotes survival and supports cardiac and
skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab. 12:
362–372; 2010.
[119] Ames, B. N. Increasing longevity by tuning up metabolism: to maximize human
health and lifespan, scientists must abandon outdated models of micronutrients.
EMBO Rep. 6:S20–S24 (Special Issue); 2005.
[120] Warburton, D. E.; Nicol, C. W.; Bredin, S. S. Health beneﬁts of physical activity:
the evidence. Can. Med. Assoc. J. 174:801–809; 2006.
[121] Lanza, I. R.; Short, D. K.; Short, K. R.; Raghavakaimal, S.; Basu, R.; Joyner, M. J.;
McConnell, J. P.; Nair, K. S. Endurance exercise as a countermeasure for aging.
Diabetes 57:2933–2942; 2008.
[122] Zarse, K.; Bossecker, A.; Muller-Kuhrt, L.; Siems, K.; Hernandez, M. A.;
Berendsohn, W. G.; Birringer, M.; Ristow, M. The phytochemical glaucarubinone
promotes mitochondrial metabolism, reduces body fat, and extends lifespan of
Caenorhabditis elegans. Horm. Metab. Res. 43:241–243; 2011.
[123] Schulz, T. J.;Westermann, D.; Isken, F.; Voigt, A.; Laube, B.; Thierbach, R.; Kuhlow,
D.; Zarse, K.; Schomburg, L.; Pfeiffer, A. F. H.; Tschöpe, C.; Ristow, M. Activation of
mitochondrial energy metabolism protects against cardiac failure. Aging
(Albany) 2:843–853; 2010.
[124] Bonawitz, N. D.; Rodeheffer, M. S.; Shadel, G. S. Defective mitochondrial gene
expression results in reactive oxygen species-mediated inhibition of respiration
and reduction of yeast life span. Mol. Cell. Biol. 26:4818–4829; 2006.
[125] Zarse, K.; Schulz, T. J.; Birringer, M.; Ristow, M. Impaired respiration is positively
correlated with decreased life span in Caenorhabditis elegans models of
Friedreich ataxia. FASEB J. 21:1271–1275; 2007.
334 M. Ristow, S. Schmeisser / Free Radical Biology & Medicine 51 (2011) 327–336[126] Thierbach, R.; Schulz, T. J.; Isken, F.; Voigt, A.; Mietzner, B.; Drewes, G.; von
Kleist-Retzow, J. C.; Wiesner, R. J.; Magnuson, M. A.; Puccio, H.; Pfeiffer, A. F.;
Steinberg, P.; Ristow, M. Targeted disruption of hepatic frataxin expression
causes impaired mitochondrial function, decreased life span, and tumor growth
in mice. Hum. Mol. Genet. 14:3857–3864; 2005.
[127] Powers III, R. W.; Kaeberlein, M.; Caldwell, S. D.; Kennedy, B. K.; Fields, S.
Extension of chronological life span in yeast by decreased TOR pathway
signaling. Genes Dev. 20:174–184; 2006.
[128] Bonawitz, N. D.; Chatenay-Lapointe, M.; Pan, Y.; Shadel, G. S. Reduced TOR
signaling extends chronological life span via increased respiration and
upregulation of mitochondrial gene expression. Cell Metab. 5:265–277; 2007.
[129] Zid, B. M.; Rogers, A. N.; Katewa, S. D.; Vargas, M. A.; Kolipinski, M. C.; Lu, T. A.;
Benzer, S.; Kapahi, P. 4E-BP extends lifespan upon dietary restriction by
enhancing mitochondrial activity in Drosophila. Cell 139:149–160; 2009.
[130] Gwinn, D. M.; Shackelford, D. B.; Egan, D. F.; Mihaylova, M.M.; Mery, A.; Vasquez,
D. S.; Turk, B. E.; Shaw, R. J. AMPK phosphorylation of raptor mediates a
metabolic checkpoint. Mol. Cell 30:214–226; 2008.
[131] Harman, D. The biologic clock: themitochondria? J. Am. Geriatr. Soc. 20:145–147;
1972.
[132] Lapointe, J.; Hekimi, S. When a theory of aging ages badly. Cell. Mol. Life Sci. 67:
1–8; 2010.
[133] Harrington, L. A.; Harley, C. B. Effect of vitamin E on lifespan and reproduction in
Caenorhabditis elegans. Mech. Ageing Dev. 43:71–78; 1988.
[134] Phillips, J. P.; Campbell, S. D.; Michaud, D.; Charbonneau, M.; Hilliker, A. J. Null
mutation of copper/zinc superoxide dismutase in Drosophila confers hypersen-
sitivity to paraquat and reduced longevity. Proc. Natl Acad. Sci. U. S. A. 86:
2761–2765; 1989.
[135] Orr, W. C.; Sohal, R. S. Extension of life-span by overexpression of superoxide
dismutase and catalase in Drosophila melanogaster. Science 263:1128–1130;
1994.
[136] Parkes, T. L.; Elia, A. J.; Dickinson, D.; Hilliker, A. J.; Phillips, J. P.; Boulianne, G. L.
Extension of Drosophila lifespan by overexpression of human SOD1 in
motorneurons. Nat. Genet. 19:171–174; 1998.
[137] Melov, S.; Ravenscroft, J.; Malik, S.; Gill, M. S.; Walker, D. W.; Clayton, P. E.;
Wallace, D. C.; Malfroy, B.; Doctrow, S. R.; Lithgow, G. J. Extension of life-span
with superoxide dismutase/catalase mimetics. Science 289:1567–1569; 2000.
[138] Moskovitz, J.; Bar-Noy, S.;Williams,W.M.; Requena, J.; Berlett, B. S.; Stadtman, E.
R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense
and lifespan in mammals. Proc. Natl Acad. Sci. U. S. A. 98:12920–12925; 2001.
[139] Bakaev, V. V.; Lyudmila, M. B. Effect of ascorbic acid on longevity in the nematoda
Caenorhabditis elegans. Biogerontology 3 (Suppl. 1):12–16; 2002.
[140] Ruan, H.; Tang, X. D.; Chen, M. L.; Joiner, M. L.; Sun, G.; Brot, N.; Weissbach, H.;
Heinemann, S. H.; Iverson, L.; Wu, C. F.; Hoshi, T. High-quality life extension by
the enzyme peptide methionine sulfoxide reductase. Proc. Natl Acad. Sci. U. S. A.
99:2748–2753; 2002.
[141] Ishii, N.; Senoo-Matsuda, N.; Miyake, K.; Yasuda, K.; Ishii, T.; Hartman, P. S.;
Furukawa, S. Coenzyme Q10 can prolong C. elegans lifespan by lowering
oxidative stress. Mech. Ageing Dev. 125:41–46; 2004.
[142] Huang, T. T.; Naeemuddin, M.; Elchuri, S.; Yamaguchi, M.; Kozy, H. M.; Carlson, E.
J.; Epstein, C. J. Genetic modiﬁers of the phenotype of mice deﬁcient in
mitochondrial superoxide dismutase. Hum. Mol. Genet. 15:1187–1194; 2006.
[143] Zou, S.; Sinclair, J.; Wilson, M. A.; Carey, J. R.; Liedo, P.; Oropeza, A.; Kalra, A.; de
Cabo, R.; Ingram, D. K.; Longo, D. L.; Wolkow, C. A. Comparative approaches to
facilitate the discovery of prolongevity interventions: effects of tocopherols on
lifespan of three invertebrate species. Mech. Ageing Dev. 128:222–226; 2007.
[144] Kim, J.; Takahashi, M.; Shimizu, T.; Shirasawa, T.; Kajita, M.; Kanayama, A.;
Miyamoto, Y. Effects of a potent antioxidant, platinum nanoparticle, on the
lifespan of Caenorhabditis elegans. Mech. Ageing Dev. 129:322–331; 2008.
[145] Quick, K. L.; Ali, S. S.; Arch, R.; Xiong, C.; Wozniak, D.; Dugan, L. L. A
carboxyfullerene SOD mimetic improves cognition and extends the lifespan of
mice. Neurobiol. Aging 29:117–128; 2008.
[146] Dai, D. F.; Santana, L. F.; Vermulst, M.; Tomazela, D. M.; Emond, M. J.; MacCoss, M.
J.; Gollahon, K.; Martin, G. M.; Loeb, L. A.; Ladiges, W. C.; Rabinovitch, P. S.
Overexpression of catalase targeted to mitochondria attenuates murine cardiac
aging. Circulation 119:2789–2797; 2009.
[147] Shibamura, A.; Ikeda, T.; Nishikawa, Y. A method for oral administration of
hydrophilic substances to Caenorhabditis elegans: effects of oral supplementa-
tion with antioxidants on the nematode lifespan. Mech. Ageing Dev. 130:
652–655; 2009.
[148] Greenberg, E. R.; Baron, J. A.; Tosteson, T. D.; Freeman Jr., D. H.; Beck, G. J.; Bond, J.
H.; Colacchio, T. A.; Coller, J. A.; Frankl, H. D.; Haile, R. W., et al. A clinical trial of
antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study
Group. N. Engl. J. Med. 331:141–147; 1994.
[149] Liu, S.; Ajani, U.; Chae, C.; Hennekens, C.; Buring, J. E.; Manson, J. E. Long-term
beta-carotene supplementation and risk of type 2 diabetes mellitus: a
randomized controlled trial. JAMA 282:1073–1075; 1999.
[150] Rautalahti, M. T.; Virtamo, J. R.; Taylor, P. R.; Heinonen, O. P.; Albanes, D.; Haukka,
J. K.; Edwards, B. K.; Karkkainen, P. A.; Stolzenberg-Solomon, R. Z.; Huttunen, J.
The effects of supplementation with alpha-tocopherol and beta-carotene on the
incidence and mortality of carcinoma of the pancreas in a randomized,
controlled trial. Cancer 86:37–42; 1999.
[151] Virtamo, J.; Edwards, B. K.; Virtanen, M.; Taylor, P. R.; Malila, N.; Albanes, D.;
Huttunen, J. K.; Hartman, A. M.; Hietanen, P.; Maenpaa, H.; Koss, L.; Nordling, S.;
Heinonen, O. P. Effects of supplemental alpha-tocopherol and beta-carotene on
urinary tract cancer: incidence and mortality in a controlled trial (Finland).
Cancer Causes Control 11:933–939; 2000.[152] Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of
antioxidant vitamin supplementation in 20,536 high-risk individuals: a
randomised placebo-controlled trial. Lancet 360:23–33; 2002.
[153] Sacco, M.; Pellegrini, F.; Roncaglioni, M. C.; Avanzini, F.; Tognoni, G.; Nicolucci, A.
Primary prevention of cardiovascular events with low-dose aspirin and vitamin
E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
Diabetes Care 26:3264–3272; 2003.
[154] Zureik, M.; Galan, P.; Bertrais, S.; Mennen, L.; Czernichow, S.; Blacher, J.;
Ducimetiere, P.; Hercberg, S. Effects of long-term daily low-dose supplementa-
tion with antioxidant vitamins and minerals on structure and function of large
arteries. Arterioscler. Thromb. Vasc. Biol. 24:1485–1491; 2004.
[155] Czernichow, S.; Bertrais, S.; Blacher, J.; Galan, P.; Briancon, S.; Favier, A.; Safar, M.;
Hercberg, S. Effect of supplementation with antioxidants upon long-term risk of
hypertension in the SU.VI.MAX study: association with plasma antioxidant
levels. J. Hypertens. 23:2013–2018; 2005.
[156] Czernichow, S.; Couthouis, A.; Bertrais, S.; Vergnaud, A. C.; Dauchet, L.; Galan, P.;
Hercberg, S. Antioxidant supplementation does not affect fasting plasma glucose
in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX)
study in France: association with dietary intake and plasma concentrations. Am.
J. Clin. Nutr. 84:395–399; 2006.
[157] Cook, N. R.; Albert, C. M.; Gaziano, J. M.; Zaharris, E.; MacFadyen, J.; Danielson, E.;
Buring, J. E.; Manson, J. E. A randomized factorial trial of vitamins C and E and
beta carotene in the secondary prevention of cardiovascular events in women:
results from the Women's Antioxidant Cardiovascular Study. Arch. Intern. Med.
167:1610–1618; 2007.
[158] Kataja-Tuomola, M.; Sundell, J. R.; Mannisto, S.; Virtanen, M. J.; Kontto, J.;
Albanes, D.; Virtamo, J. Effect of alpha-tocopherol and beta-carotene supple-
mentation on the incidence of type 2 diabetes. Diabetologia 51:47–53; 2008.
[159] Sesso, H. D.; Buring, J. E.; Christen, W. G.; Kurth, T.; Belanger, C.; MacFadyen, J.;
Bubes, V.; Manson, J. E.; Glynn, R. J.; Gaziano, J. M. Vitamins E and C in the
prevention of cardiovascular disease in men: the Physicians' Health Study II
randomized controlled trial. JAMA 300:2123–2133; 2008.
[160] Katsiki, N.; Manes, C. Is there a role for supplemented antioxidants in the
prevention of atherosclerosis? Clin. Nutr. 28:3–9; 2009.
[161] Lin, J.; Cook, N. R.; Albert, C.; Zaharris, E.; Gaziano, J. M.; Van Denburgh, M.;
Buring, J. E.; Manson, J. E. Vitamins C and E and beta-carotene supplementation
and cancer risk: a randomized controlled trial. J. Natl. Cancer Inst. 101:14–23;
2009.
[162] Song, Y.; Cook, N. R.; Albert, C. M.; Van Denburgh, M.; Manson, J. E. Effects of
vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at
high risk of cardiovascular disease: a randomized controlled trial. Am. J. Clin.
Nutr. 90:429–437; 2009.
[163] Bjelakovic, G.; Nikolova, D.; Simonetti, R. G.; Gluud, C. Antioxidant supplements
for prevention of gastrointestinal cancers: a systematic review and meta-
analysis. Lancet 364:1219–1228; 2004.
[164] Bairati, I.; Meyer, F.; Gelinas, M.; Fortin, A.; Nabid, A.; Brochet, F.; Mercier, J. P.;
Tetu, B.; Harel, F.; Masse, B.; Vigneault, E.; Vass, S.; del Vecchio, P.; Roy, J. A
randomized trial of antioxidant vitamins to prevent second primary cancers in
head and neck cancer patients. J. Natl. Cancer Inst. 97:481–488; 2005.
[165] Hercberg, S.; Ezzedine, K.; Guinot, C.; Preziosi, P.; Galan, P.; Bertrais, S.; Estaquio,
C.; Briancon, S.; Favier, A.; Latreille, J.; Malvy, D. Antioxidant supplementation
increases the risk of skin cancers in women but not in men. J. Nutr. 137:
2098–2105; 2007.
[166] Bardia, A.; Tleyjeh, I. M.; Cerhan, J. R.; Sood, A. K.; Limburg, P. J.; Erwin, P. J.;
Montori, V. M. Efﬁcacy of antioxidant supplementation in reducing primary
cancer incidence andmortality: systematic review andmeta-analysis.Mayo Clin.
Proc. 83:23–34; 2008.
[167] Lawenda, B. D.; Kelly, K. M.; Ladas, E. J.; Sagar, S. M.; Vickers, A.; Blumberg, J. B.
Should supplemental antioxidant administration be avoided during chemother-
apy and radiation therapy? J. Natl. Cancer Inst. 100:773–783; 2008.
[168] Myung, S. K.; Kim, Y.; Ju, W.; Choi, H. J.; Bae, W. K. Effects of antioxidant
supplements on cancer prevention: meta-analysis of randomized controlled
trials. Ann. Oncol. 21:166–179; 2010.
[169] Albanes, D.; Heinonen, O. P.; Taylor, P. R.; Virtamo, J.; Edwards, B. K.; Rautalahti,
M.; Hartman, A. M.; Palmgren, J.; Freedman, L. S.; Haapakoski, J.; Barrett, M. J.;
Pietinen, P.; Malila, N.; Tala, E.; Liippo, K.; Salomaa, E. R.; Tangrea, J. A.; Teppo, L.;
Askin, F. B.; Taskinen, E.; Erozan, Y.; Greenwald, P.; Huttunen, J. K. Alpha-
Tocopherol and beta-carotene supplements and lung cancer incidence in the
alpha-Tocopherol, beta-Carotene Cancer Prevention Study: effects of base-line
characteristics and study compliance. J. Natl. Cancer Inst. 88:1560–1570; 1996.
[170] Omenn, G. S.; Goodman, G. E.; Thornquist, M. D.; Balmes, J.; Cullen, M. R.; Glass,
A.; Keogh, J. P.; Meyskens, F. L.; Valanis, B.; Williams, J. H.; Barnhart, S.; Hammar,
S. Effects of a combination of beta carotene and vitamin A on lung cancer and
cardiovascular disease. N. Engl. J. Med. 334:1150–1155; 1996.
[171] Vivekananthan, D. P.; Penn, M. S.; Sapp, S. K.; Hsu, A.; Topol, E. J. Use of
antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis
of randomised trials. Lancet 361:2017–2023; 2003.
[172] Lonn, E.; Bosch, J.; Yusuf, S.; Sheridan, P.; Pogue, J.; Arnold, J. M.; Ross, C.; Arnold,
A.; Sleight, P.; Probstﬁeld, J.; Dagenais, G. R. Effects of long-term vitamin E
supplementation on cardiovascular events and cancer: a randomized controlled
trial. JAMA 293:1338–1347; 2005.
[173] Bjelakovic, G.; Nikolova, D.; Gluud, L. L.; Simonetti, R. G.; Gluud, C. Mortality in
randomized trials of antioxidant supplements for primary and secondary
prevention: systematic review and meta-analysis. JAMA 297:842–857; 2007.
[174] Ward, N. C.;Wu, J. H.; Clarke, M.W.; Puddey, I. B.; Burke, V.; Croft, K. D.; Hodgson,
J. M. The effect of vitamin E on blood pressure in individuals with type 2
335M. Ristow, S. Schmeisser / Free Radical Biology & Medicine 51 (2011) 327–336diabetes: a randomized, double-blind, placebo-controlled trial. J. Hypertens. 25:
227–234; 2007.
[175] Lippman, S. M.; Klein, E. A.; Goodman, P. J.; Lucia, M. S.; Thompson, I. M.; Ford, L.
G.; Parnes, H. L.; Minasian, L. M.; Gaziano, J. M.; Hartline, J. A.; Parsons, J. K.;
Bearden III, J. D.; Crawford, E. D.; Goodman, G. E.; Claudio, J.; Winquist, E.; Cook,
E. D.; Karp, D. D.; Walther, P.; Lieber, M. M.; Kristal, A. R.; Darke, A. K.; Arnold, K.
B.; Ganz, P. A.; Santella, R. M.; Albanes, D.; Taylor, P. R.; Probstﬁeld, J. L.; Jagpal, T.
J.; Crowley, J. J.; Meyskens Jr., F. L.; Baker, L. H.; Coltman Jr., C. A. Effect of
selenium and vitamin E on risk of prostate cancer and other cancers: the
Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:39–51;
2009.
[176] Barja, G. Oxygen radicals, a failure or a success of evolution? Free Radic. Res.
Commun. 18:63–70; 1993.
[177] Rhee, S. G.; Chang, T. S.; Bae, Y. S.; Lee, S. R.; Kang, S. W. Cellular regulation by
hydrogen peroxide. J. Am. Soc. Nephrol. 14:S211–S215; 2003.
[178] Kaelin Jr., W. G. ROS: really involved in oxygen sensing. Cell Metab. 1:357–358;
2005.
[179] Connor, K. M.; Subbaram, S.; Regan, K. J.; Nelson, K. K.; Mazurkiewicz, J. E.;
Bartholomew, P. J.; Aplin, A. E.; Tai, Y. T.; Aguirre-Ghiso, J.; Flores, S. C.; Melendez,
J. A. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation.
J. Biol. Chem. 280:16916–16924; 2005.
[180] Guzy, R. D.; Hoyos, B.; Robin, E.; Chen, H.; Liu, L.; Mansﬁeld, K. D.; Simon, M. C.;
Hammerling, U.; Schumacker, P. T. Mitochondrial complex III is required for
hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1:
401–408; 2005.
[181] Guzy, R. D.; Schumacker, P. T. Oxygen sensing by mitochondria at complex III:
the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol.
91:807–819; 2006.
[182] Chandel, N. S.; Budinger, G. R. The cellular basis for diverse responses to oxygen.
Free Radic. Biol. Med. 42:165–174; 2007.
[183] Veal, E. A.; Day, A. M.; Morgan, B. A. Hydrogen peroxide sensing and signaling.
Mol. Cell 26:1–14; 2007.
[184] Owusu-Ansah, E.; Yavari, A.; Mandal, S.; Banerjee, U. Distinct mitochondrial
retrograde signals control the G1–S cell cycle checkpoint. Nat. Genet. 40:
356–361; 2008.
[185] Finley, L. W.; Haigis, M. C. The coordination of nuclear and mitochondrial
communication during aging and calorie restriction. Ageing Res. Rev. 8:173–188;
2009.
[186] Ristow, M.; Zarse, K.; Oberbach, A.; Klöting, N.; Birringer, M.; Kiehntopf, M.;
Stumvoll, M.; Kahn, C. R.; Blüher, M. Antioxidants prevent health-promoting
effects of physical exercise in humans. Proc. Natl Acad. Sci. U. S. A. 106:
8665–8670; 2009.
[187] Loh, K.; Deng, H.; Fukushima, A.; Cai, X.; Boivin, B.; Galic, S.; Bruce, C.; Shields, B.
J.; Skiba, B.; Ooms, L. M.; Stepto, N.; Wu, B.; Mitchell, C. A.; Tonks, N. K.; Watt, M.
J.; Febbraio, M. A.; Crack, P. J.; Andrikopoulos, S.; Tiganis, T. Reactive oxygen
species enhance insulin sensitivity. Cell Metab. 10:260–272; 2009.
[188] Lee, S. J.; Hwang, A. B.; Kenyon, C. Inhibition of respiration extends C. elegans life
span via reactive oxygen species that increase HIF-1 activity. Curr. Biol. 20:
2131–2136; 2010.
[189] Yang, W.; Hekimi, S. A Mitochondrial superoxide signal triggers increased
longevity in Caenorhabditis elegans. PLoS Biol. 8:e1000556; 2010.
[190] Woo, D. K.; Shadel, G. S. Mitochondrial stress signals revise an old aging theory.
Cell 144:11–12; 2011.
[191] Boveris, A.; Chance, B. The mitochondrial generation of hydrogen peroxide:
general properties and effect of hyperbaric oxygen. Biochem. J. 134:707–716;
1973.
[192] Cypser, J. R.; Johnson, T. E. Multiple stressors in Caenorhabditis elegans induce
stress hormesis and extended longevity. J. Gerontol. A Biol. Sci. Med. Sci. 57:
B109–B114; 2002.
[193] Yanase, S.; Hartman, P. S.; Ito, A.; Ishii, N. Oxidative stress pretreatment increases
the X-radiation resistance of the nematode Caenorhabditis elegans. Mutat. Res.
426:31–39; 1999.
[194] Turrens, J. F. Mitochondrial formation of reactive oxygen species. J. Physiol. 552:
335–344; 2003.
[195] Conti, B.; Sanchez-Alavez, M.; Winsky-Sommerer, R.; Morale, M. C.; Lucero, J.;
Brownell, S.; Fabre, V.; Huitron-Resendiz, S.; Henriksen, S.; Zorrilla, E. P.; de
Lecea, L.; Bartfai, T. Transgenic mice with a reduced core body temperature have
an increased life span. Science 314:825–828; 2006.
[196] Hosono, R.; Mitsui, Y.; Sato, Y.; Aizawa, S.; Miwa, J. Life span of the wild and
mutant nematode Caenorhabditis elegans: effects of sex, sterilization, and
temperature. Exp. Gerontol. 17:163–172; 1982.
[197] Ali, S. S.; Marcondes, M. C.; Bajova, H.; Dugan, L. L.; Conti, B. Metabolic depression
and increased ROS production by isolated mitochondria at moderately lower
temperatures. J. Biol. Chem. 285:32522–32528; 2010.
[198] Masoro, E. J. Inﬂuence of caloric intake on aging and on the response to stressors.
J. Toxicol. Environ. Health B Crit. Rev. 1:243–257; 1998.
[199] Yu, B. P.; Chung, H. Y. Stress resistance by caloric restriction for longevity. Ann. N.
Y. Acad. Sci. 928:39–47; 2001.
[200] Masoro, E. J. The role of hormesis in life extension by dietary restriction.
Interdiscip. Top. Gerontol. 35:1–17; 2007.
[201] Southam, C. M.; Ehrlich, J. Effects of extract of western red-cedar heartwood on
certain wood-decaying fungi in culture. Phytopathology 33:517–524; 1943.
[202] Calabrese, E. J.; Baldwin, L. A. Deﬁning hormesis. Hum. Exp. Toxicol. 21:91–97;
2002.
[203] Cypser, J. R.; Tedesco, P.; Johnson, T. E. Hormesis and aging in Caenorhabditis
elegans. Exp. Gerontol. 41:935–939; 2006.[204] Rattan, S. I. Hormesis in aging. Ageing Res. Rev. 7:63–78; 2008.
[205] Mattson, M. P. Hormesis deﬁned. Ageing Res. Rev. 7:1–7; 2008.
[206] Tapia, P. C. Sublethal mitochondrial stress with an attendant stoichiometric
augmentation of reactive oxygen species may precipitate many of the beneﬁcial
alterations in cellular physiology produced by caloric restriction, intermittent
fasting, exercise and dietary phytonutrients: 'mitohormesis' for health and
vitality. Med. Hypotheses 66:832–843; 2006.
[207] Sreekumar, R.; Unnikrishnan, J.; Fu, A.; Nygren, J.; Short, K. R.; Schimke, J.;
Barazzoni, R.; Nair, K. S. Effects of caloric restriction on mitochondrial function
and gene transcripts in rat muscle. Am. J. Physiol. Endocrinol. Metab. 283:
E38–E43; 2002.
[208] Kharade, S. V.; Mittal, N.; Das, S. P.; Sinha, P.; Roy, N. Mrg19 depletion increases
S. cerevisiae lifespan by augmenting ROS defence. FEBS Lett. 579:6809–6813;
2005.
[209] Piper, P. W.; Harris, N. L.; MacLean, M. Preadaptation to efﬁcient respiratory
maintenance is essential both for maximal longevity and the retention of
replicative potential in chronologically ageing yeast. Mech. Ageing Dev. 127:
733–740; 2006.
[210] Huang, T. T.; Carlson, E. J.; Gillespie, A. M.; Shi, Y.; Epstein, C. J. Ubiquitous
overexpression of CuZn superoxide dismutase does not extend life span in mice.
J. Gerontol. A Biol. Sci. Med. Sci. 55:B5–B9; 2000.
[211] Bayne, A. C.; Sohal, R. S. Effects of superoxide dismutase/catalase mimetics on life
span and oxidative stress resistance in the houseﬂy,Musca domestica. Free Radic.
Biol. Med. 32:1229–1234; 2002.
[212] Keaney, M.; Gems, D. No increase in lifespan in Caenorhabditis elegans upon
treatment with the superoxide dismutase mimetic EUK-8. Free Radic. Biol. Med.
34:277–282; 2003.
[213] Andziak, B.; O'Connor, T. P.; Qi, W.; DeWaal, E. M.; Pierce, A.; Chaudhuri, A. R.;
Van Remmen, H.; Buffenstein, R. High oxidative damage levels in the longest-
living rodent, the naked mole-rat. Aging Cell 5:463–471; 2006.
[214] Selman, C.; McLaren, J. S.; Meyer, C.; Duncan, J. S.; Redman, P.; Collins, A. R.;
Duthie, G. G.; Speakman, J. R. Life-long vitamin C supplementation in
combination with cold exposure does not affect oxidative damage or lifespan
in mice, but decreases expression of antioxidant protection genes. Mech. Ageing
Dev. 127:897–904; 2006.
[215] Ran, Q.; Liang, H.; Ikeno, Y.; Qi, W.; Prolla, T. A.; Roberts II, L. J.; Wolf, N.; Van
Remmen, H.; Richardson, A. Reduction in glutathione peroxidase 4 increases life
span through increased sensitivity to apoptosis. J. Gerontol. A Biol. Sci. Med. Sci.
62:932–942; 2007.
[216] Doonan, R.; McElwee, J. J.; Matthijssens, F.; Walker, G. A.; Houthoofd, K.; Back, P.;
Matscheski, A.; Vanﬂeteren, J. R.; Gems, D. Against the oxidative damage theory
of aging: superoxide dismutases protect against oxidative stress but have little
or no effect on life span in Caenorhabditis elegans. Genes Dev. 22:3236–3241;
2008.
[217] Heidler, T.; Hartwig, K.; Daniel, H.; Wenzel, U. Caenorhabditis elegans lifespan
extension caused by treatment with an orally active ROS-generator is dependent
on DAF-16 and SIR-2.1. Biogerontology 11:183–195; 2010.
[218] Jang, Y. C.; van Remmen, H. The mitochondrial theory of aging: insight from
transgenic and knockout mouse models. Exp. Gerontol. 44:256–260; 2009.
[219] Jang, Y. C.; Perez, V. I.; Song, W.; Lustgarten, M. S.; Salmon, A. B.; Mele, J.; Qi, W.;
Liu, Y.; Liang, H.; Chaudhuri, A.; Ikeno, Y.; Epstein, C. J.; Van Remmen, H.;
Richardson, A. Overexpression of Mn superoxide dismutase does not increase
life span in mice. J. Gerontol. A Biol. Sci. Med. Sci. 64:1114–1125; 2009.
[220] Lapointe, J.; Stepanyan, Z.; Bigras, E.; Hekimi, S. Reversal of the mitochondrial
phenotype and slow development of oxidative biomarkers of aging in long-lived
Mclk1+/− mice. J. Biol. Chem. 284:20364–20374; 2009.
[221] Van Raamsdonk, J. M.; Hekimi, S. Deletion of the mitochondrial superoxide
dismutase sod-2 extends lifespan in Caenorhabditis elegans. PLoS Genet. 5:
e1000361; 2009.
[222] Yen, K.; Patel, H. B.; Lublin, A. L.; Mobbs, C. V. SOD isoforms play no role in
lifespan in ad lib or dietary restricted conditions, but mutational inactivation of
SOD-1 reduces life extension by cold. Mech. Ageing Dev. 130:173–178; 2009.
[223] Zhang, Y.; Ikeno, Y.; Qi, W.; Chaudhuri, A.; Li, Y.; Bokov, A.; Thorpe, S. R.; Baynes,
J. W.; Epstein, C.; Richardson, A.; Van Remmen, H. Mice deﬁcient in both Mn
superoxide dismutase and glutathione peroxidase-1 have increased oxidative
damage and a greater incidence of pathology but no reduction in longevity. J.
Gerontol. A Biol. Sci. Med. Sci. 64:1212–1220; 2009.
[224] Pun, P. B.; Gruber, J.; Tang, S. Y.; Schaffer, S.; Ong, R. L.; Fong, S.; Ng, L. F.; Cheah, I.;
Halliwell, B. Ageing in nematodes: do antioxidants extend lifespan in
Caenorhabditis elegans? Biogerontology 11:17–30; 2010.
[225] Sanz, A.; Fernandez-Ayala, D. J.; Stefanatos, R. K.; Jacobs, H. T. Mitochondrial ROS
production correlates with, but does not directly regulate lifespan in Drosophila.
Aging (Albany) 2:200–203; 2010.
[226] Zintel, S.; Schwitalla, D.; Luce, K.; Hamann, A.; Osiewacz, H. D. Increasing
mitochondrial superoxide dismutase abundance leads to impairments in protein
quality control and ROS scavenging systems and to lifespan shortening. Exp.
Gerontol. 45:525–532; 2010.
[227] Lam, Y. T.; Stocker, R.; Dawes, I. W. The lipophilic antioxidants α-tocopherol and
coenzyme Q10 reduce the replicative lifespan of Saccharomyces cerevisiae. Free
Radic. Biol. Med. 49:237–244; 2010.
[228] Lithgow, G. J.; White, T. M.; Melov, S.; Johnson, T. E. Thermotolerance and
extended life-span conferred by single-gene mutations and induced by thermal
stress. Proc. Natl Acad. Sci. U. S. A. 92:7540–7544; 1995.
[229] Vanﬂeteren, J. R.; De Vreese, A. The gerontogenes age-1 and daf-2 determine
metabolic rate potential in aging Caenorhabditis elegans. FASEB J. 9:1355–1361;
1995.
336 M. Ristow, S. Schmeisser / Free Radical Biology & Medicine 51 (2011) 327–336[230] Honda, Y.; Honda, S. The daf-2 gene network for longevity regulates oxidative
stress resistance and Mn-superoxide dismutase gene expression in Caenorhab-
ditis elegans. FASEB J. 13:1385–1393; 1999.
[231] Murphy, C. T.; McCarroll, S. A.; Bargmann, C. I.; Fraser, A.; Kamath, R. S.; Ahringer,
J.; Li, H.; Kenyon, C. Genes that act downstream of DAF-16 to inﬂuence the
lifespan of Caenorhabditis elegans. Nature 424:277–283; 2003.
[232] Houthoofd, K.; Fidalgo, M. A.; Hoogewijs, D.; Braeckman, B. P.; Lenaerts, I.; Brys,
K.; Matthijssens, F.; De Vreese, A.; Van Eygen, S.; Munoz, M. J.; Vanﬂeteren, J. R.
Metabolism, physiology and stress defense in three aging Ins/IGF-1 mutants of
the nematode Caenorhabditis elegans. Aging Cell 4:87–95; 2005.
[233] Dong, M. Q.; Venable, J. D.; Au, N.; Xu, T.; Park, S. K.; Cociorva, D.; Johnson, J. R.;
Dillin, A.; Yates III, J. R. Quantitative mass spectrometry identiﬁes insulin
signaling targets in C. elegans. Science 317:660–663; 2007.
[234] Arumugam, T. V.; Gleichmann, M.; Tang, S. C.; Mattson, M. P. Hormesis/
preconditioning mechanisms, the nervous system and aging. Ageing Res. Rev. 5:
165–178; 2006.
[235] El-Khoury, R.; Sainsard-Chanet, A. Deletion of the mitochondrial NADH kinase
increases mitochondrial DNA stability and life span in the ﬁlamentous fungus
Podospora anserina. Exp. Gerontol. 45:543–549; 2010.
[236] Nazarewicz, R. R.; Ziolkowski, W.; Vaccaro, P. S.; Ghafourifar, P. Effect of short-
term ketogenic diet on redox status of human blood. Rejuvenation Res. 10:
435–440; 2007.[237] Higuchi, M.; Cartier, L. J.; Chen, M.; Holloszy, J. O. Superoxide dismutase and
catalase in skeletal muscle: adaptive response to exercise. J. Gerontol. 40:
281–286; 1985.
[238] Lindsted, K. D.; Tonstad, S.; Kuzma, J. W. Self-report of physical activity and
patterns of mortality in Seventh-Day Adventist men. J. Clin. Epidemiol. 44:
355–364; 1991.
[239] Manini, T. M.; Everhart, J. E.; Patel, K. V.; Schoeller, D. A.; Colbert, L. H.; Visser, M.;
Tylavsky, F.; Bauer, D. C.; Goodpaster, B. H.; Harris, T. B. Daily activity energy
expenditure and mortality among older adults. JAMA 296:171–179; 2006.
[240] Davies, K. J.; Quintanilha, A. T.; Brooks, G. A.; Packer, L. Free radicals and tissue
damage produced by exercise. Biochem. Biophys. Res. Commun. 107:1198–1205;
1982.
[241] Chevion, S.; Moran, D. S.; Heled, Y.; Shani, Y.; Regev, G.; Abbou, B.; Berenshtein,
E.; Stadtman, E. R.; Epstein, Y. Plasma antioxidant status and cell injury after
severe physical exercise. Proc. Natl Acad. Sci. U. S. A. 100:5119–5123; 2003.
[242] Powers, S. K.; Jackson, M. J. Exercise-induced oxidative stress: cellular
mechanisms and impact on muscle force production. Physiol. Rev. 88:
1243–1276; 2008.
[243] Gomez-Cabrera, M. C.; Domenech, E.; Romagnoli, M.; Arduini, A.; Borras, C.;
Pallardo, F. V.; Sastre, J.; Vina, J. Oral administration of vitamin C decreases
muscle mitochondrial biogenesis and hampers training-induced adaptations in
endurance performance. Am. J. Clin. Nutr. 87:142–149; 2008.
